Screener
Tectonic Therapeutics TECX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 10) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 18,830,436 and 18,738,249 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in capital | 478,393 | 474,160 |
| Accumulated other comprehensive loss | — | (96) |
| Accumulated deficit | (247,978) | (222,737) |
| Total stockholders’ equity | 230,417 | 251,329 |
| Total liabilities and stockholders’ equity | $246,577 | $261,038 |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's retained earnings?
- Tectonic Therapeutics (TECX) reported retained earnings of -$247.98M in Q1 2026.
- How has Tectonic Therapeutics's retained earnings changed year-over-year?
- Tectonic Therapeutics's retained earnings decreased by 50.8% year-over-year, from -$164.49M to -$247.98M.
- What is the long-term trend for Tectonic Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), Tectonic Therapeutics's retained earnings has grown at a -3.4% compound annual growth rate (CAGR), from -$264.42M to -$222.74M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Tectonic Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude